The current US Supreme Court has no fundamental understanding of a range of medical, engineering, technological, or ...

Amgen’s next-generation cholesterol drug ... The company’s Repatha (evolocumab) was added to optimised statin therapy in a phase 3 trial, and resulted in statistically significant regression ...

As the Horizon acquisition reaps its benefits, Amgen is now turning eyes to its obesity and diabetes portfolio.

Repatha (evolocumab) will be sold in the UK at a cost of $6,780 per year, less than half the $14,100 Amgen is charging for the drug in the US, with the price in other EU markets typically below ...

THOUSAND OAKS, Calif., Oct. 30, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2024.

Both evolocumab and alirocumab have been reported ... fees and has served as an advisor to Sanofi-Aventis, Genzyme and Amgen Corporation. The authors have no other relevant affiliations or ...

GF Watts has received lecture fees and has served as an advisor to Sanofi-Aventis, Genzyme and Amgen Corporation ... receptors on the hepatocyte surface. Evolocumab reduces plasma ApoB and ...

Two fully human monoclonal antibodies to PCSK9 are currently licenced for clinical use both in the USA and the European Union: evolocumab and alirocumab ... grants and personal fees from Amgen, grants ...

To enhance operational efficiency, accuracy and compliance across its highly regulated and complex workflows, leading biopharmaceutical company Amgen Inc. has kickstarted its fully automated dream ...